Nvidia Corporation (NASDAQ:NVDA) is scheduled to reveal Q3 fiscal 2024 earnings post-market on November 21, 2023, expecting substantial revenue growth, reflective of strong market...
By Chris Wack Aurinia Pharmaceuticals said Monday that collaboration partner Otsuka Pharmaceutical filed a new drug application for voclosporin for the treatment of lupus...
BRUSSELS (Reuters) – European Union officials are finalising the “last details” of a proposed 12th package of sanctions on Russia that will include a...
Topline Pfizer shares tumbled again Monday, continuing the pharmaceutical giant’s struggles tied to declining demand for its Covid-19 products and essentially wiping out the...